Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
Read More…
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Phone805-562-3500
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$68.13 million
Profitability
Miscellaneous
Employees259
Next Earnings Date8/6/2019 (Estimated)
OptionableOptionable
Sientra (NASDAQ:SIEN) Frequently Asked Questions
What is Sientra's stock symbol?
Sientra trades on the NASDAQ under the ticker symbol "SIEN."
How were Sientra's earnings last quarter?
Sientra Inc (NASDAQ:SIEN) posted its quarterly earnings data on Wednesday, May, 8th. The medical instruments supplier reported ($0.91) earnings per share for the quarter, missing the consensus estimate of ($0.76) by $0.15. The medical instruments supplier earned $17.55 million during the quarter, compared to analyst estimates of $17 million. Sientra had a negative return on equity of 119.59% and a negative net margin of 126.32%. View Sientra's Earnings History.
When is Sientra's next earnings date?
What price target have analysts set for SIEN?
8 Wall Street analysts have issued 1-year target prices for Sientra's shares. Their forecasts range from $10.00 to $30.00. On average, they expect Sientra's share price to reach $21.1250 in the next twelve months. This suggests a possible upside of 209.8% from the stock's current price. View Analyst Price Targets for Sientra.
What is the consensus analysts' recommendation for Sientra?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sientra.
Has Sientra been receiving favorable news coverage?
News articles about SIEN stock have been trending neutral recently, InfoTrie reports. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sientra earned a news sentiment score of 0.1 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Sientra.
Who are some of Sientra's key competitors?
Some companies that are related to Sientra include Establishment Labs (ESTA), RTI Surgical (RTIX), ConforMIS (CFMS), Invacare (IVC), Lakeland Industries (LAKE), Rewalk Robotics (RWLK), Histogenics (HSGX), COLLPLANT HOLDI/S (CLGN), Precision Therapeutics (AIPT), NanoVibronix (NAOV), Bionik Laboratories (BNKL), Allied Healthcare Products (AHPI) and Avitar (AVTI).
What other stocks do shareholders of Sientra own?
Who are Sientra's key executives?
Sientra's management team includes the folowing people:
- Mr. Jeffrey M. Nugent, Chairman & CEO (Age 72)
- Mr. Charles Huiner, COO and Sr. VP of Corp. Devel. & Strategy (Age 48)
- Mr. Keith J. Sullivan, Director & Advisor to MiraDry Bus. (Age 61)
- Mr. Paul Sean Little, CFO, Sr. VP & Treasurer (Age 54)
- Ms. Deborah Bettencourt, VP of Customer Experience & Corp. Admin.
Who are Sientra's major shareholders?
Sientra's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Gilder Gagnon Howe & Co. LLC (1.41%), Quantum Capital Management (0.77%), Stephens Inc. AR (0.48%), Formula Growth Ltd. (0.41%), Marshall Wace North America L.P. (0.24%) and Tarbox Family Office Inc. (0.12%). Company insiders that own Sientra stock include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Institutional Ownership Trends for Sientra.
Which major investors are selling Sientra stock?
SIEN stock was sold by a variety of institutional investors in the last quarter, including Gilder Gagnon Howe & Co. LLC, Marshall Wace LLP and Creative Planning. Company insiders that have sold Sientra company stock in the last year include Jeffrey M Nugent and Timothy Haines. View Insider Buying and Selling for Sientra.
Which major investors are buying Sientra stock?
SIEN stock was purchased by a variety of institutional investors in the last quarter, including Stephens Inc. AR, Quantum Capital Management, Marshall Wace North America L.P., Tarbox Family Office Inc., Bailard Inc., Virtu Financial LLC, Formula Growth Ltd. and BNP Paribas Arbitrage SA. Company insiders that have bought Sientra stock in the last two years include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Insider Buying and Selling for Sientra.
How do I buy shares of Sientra?
Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Sientra's stock price today?
One share of SIEN stock can currently be purchased for approximately $6.82.
How big of a company is Sientra?
Sientra has a market capitalization of $199.25 million and generates $68.13 million in revenue each year. The medical instruments supplier earns $-82,630,000.00 in net income (profit) each year or ($3.25) on an earnings per share basis. Sientra employs 259 workers across the globe.View Additional Information About Sientra.
What is Sientra's official website?
How can I contact Sientra?
Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]
MarketBeat Community Rating for Sientra (NASDAQ SIEN)
| Community Ranking: | | 2.3 out of 5 ( ) |
| Outperform Votes: | | 202 (Thanks for Voting!) |
| Underperform Votes: | | 239 (Thanks for Voting!) |
| Total Votes: | | 441 |
